Business

Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, Adsorbed

Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, Adsorbed

articleChangchun Bcht Biotechnology Co. Class AOctober 9, 20253/news/announcement-on-voluntary-disclosure-of-approval-for-diphtheria-tetanus-pertussis-acellular-component-and-haemophilus-type-b-conjugate-vaccine-adsorbed
Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, Adsorbed

About this update from Changchun Bcht Biotechnology Co. Class A

Announcement on Voluntary Disclosure of Approval for Diphtheria, Tetanus, Pertussis (Acellular, Component) and Haemophilus Type b Conjugate Vaccine, AdsorbedThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A